DeniseHelenaSutherland-PhillipsMD

PubMed

• 3 citations
  Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir ala...
  Moti N Ramgopal, Antonella Castagna, Charles Cazanave, Vicens Diaz-Brito, Robin Dretler, Shinichi Oka, Olayemi Osiyemi, Sharon Walmsley, James Sims, Giovanni Di Perri,...> ;The Lancet. HIV. 2023 Sep 1
• 1 citations
  Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the...
  Tahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, Ahmed Hnoosh, Antonella Castagna, Peter Messiaen, Maria Jose Galindo Puerto, Mark Bloch, Eisuke Ada...> ;AIDS Patient Care and Stds. 2023 Jan 1
• 19 citations
  Safety and Efficacy of a 36-Week Induction Regimen of Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir in HIV-Infected Patients
  Kathleen Squires, Benjamin Young, Edwin DeJesus, Nicholas Bellos, Daniel Murphy, Denise H. Sutherland-Phillips, Henry H. Zhao, Lisa G. Patel, Lisa L. Ross, Paul Wannam...> ;HIV Clinical Trials. 2010 Mar 1
• 174 citations
  Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
  Kimberly Y. Smith, Parul Patel, Derek M. Fine, Nicholaos C. Bellos, Louis Sloan, Philip Lackey, Princy Kumar, Denise H Sutherland-Phillips, Cindy Vavro, Linda Yau, Pau...> ;AIDS. 2009 Jul 1
• 56 citations
  First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
  Benjamin Young, Kathleen Squires, Parul Patel, Edwin DeJesus, Nicholaos C. Bellos, Daniel S Berger, Denise H. Sutherland-Phillips, Qiming Liao, Mark S. Shaefer, Paul W...> ;AIDS. 2008 Aug 20
• 281 citations
  High Sensitivity of Human Leukocyte Antigen-B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
  Michael S. Saag, Rukmini Balu, Elizabeth J. Phillips, Philip S. Brachman, Claudia Martorell, William J. Burman, Britt Stancil, Michael Mosteller, Paul Wannamaker, Arle...> ;Clinical Infectious Diseases. 2008 Apr 1
• 8 citations
  Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate componen...
  Calvin J. Cohen, Marshall Kubota, Philip S. Brachman, William B. Harley, Stefan Schneider, Vanessa C. Williams, Denise H. Sutherland-Phillips, Michael L. Lim, Rukmini ...> ;Pharmacotherapy. 2008 Mar 1
• 271 citations
  The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 wee...
  Joseph J. Eron, Patrick Yeni, Joseph C. Gathe, Vicente Estrada, Edwin DeJesus, Schlomo Staszewski, Philip Lackey, Christine Katlama, Benjamin Young, Linda Yau, Denise ...> ;Lancet. 2006 Aug 5
• Join now to see all